Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5OHK

Crystal structure of USP30 in covalent complex with ubiquitin propargylamide (high resolution)

Summary for 5OHK
Entry DOI10.2210/pdb5ohk/pdb
DescriptorUbiquitin carboxyl-terminal hydrolase 30,Ubiquitin carboxyl-terminal hydrolase 30,Ubiquitin carboxyl-terminal hydrolase 30, Polyubiquitin-B, ZINC ION, ... (5 entities in total)
Functional Keywordsdeubiquitinase, dub, ubiquitin, usp, hydrolase
Biological sourceHomo sapiens (Human)
More
Cellular locationMitochondrion outer membrane : Q70CQ3
Ubiquitin: Cytoplasm : P0CG47
Total number of polymer chains2
Total formula weight47150.78
Authors
Gersch, M.,Komander, D. (deposition date: 2017-07-17, release date: 2017-09-20, Last modification date: 2024-02-07)
Primary citationGersch, M.,Gladkova, C.,Schubert, A.F.,Michel, M.A.,Maslen, S.,Komander, D.
Mechanism and regulation of the Lys6-selective deubiquitinase USP30.
Nat. Struct. Mol. Biol., 24:920-930, 2017
Cited by
PubMed Abstract: Damaged mitochondria undergo mitophagy, a specialized form of autophagy that is initiated by the protein kinase PINK1 and the ubiquitin E3 ligase Parkin. Ubiquitin-specific protease USP30 antagonizes Parkin-mediated ubiquitination events on mitochondria and is a key negative regulator of mitophagy. Parkin and USP30 both show a preference for assembly or disassembly, respectively, of Lys6-linked polyubiquitin, a chain type that has not been well studied. Here we report crystal structures of human USP30 bound to monoubiquitin and Lys6-linked diubiquitin, which explain how USP30 achieves Lys6-linkage preference through unique ubiquitin binding interfaces. We assess the interplay between USP30, PINK1 and Parkin and show that distally phosphorylated ubiquitin chains impair USP30 activity. Lys6-linkage-specific affimers identify numerous mitochondrial substrates for this modification, and we show that USP30 regulates Lys6-polyubiquitinated TOM20. Our work provides insights into the architecture, activity and regulation of USP30, which will aid drug design against this and related enzymes.
PubMed: 28945249
DOI: 10.1038/nsmb.3475
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.34 Å)
Structure validation

238582

数据于2025-07-09公开中

PDB statisticsPDBj update infoContact PDBjnumon